Treatment of post-transplant lymphoproliferative disease with induction chemotherapy followed by haploidentical peripheral blood stem cell transplantation and Rituximab. [electronic resource]
Producer: 20010628Description: 329-32 p. digitalISSN:- 0268-3369
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Murine-Derived
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Child, Preschool
- Disease-Free Survival
- Haplotypes -- immunology
- Hematopoietic Stem Cell Transplantation -- adverse effects
- Humans
- Lymphoma, B-Cell -- etiology
- Lymphoproliferative Disorders -- etiology
- Major Histocompatibility Complex -- genetics
- Male
- Remission Induction
- Rituximab
- Severe Combined Immunodeficiency -- complications
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.